Resources
88.1% of our customers are likely to recommend Kayentis to a colleague or friend!Thank you… | Read More
Have you anticipated all situations?Discover the key advantages of our WebCOA back-up! … | Read More
Among numerous clinical study procedures, capturing patients reported outcomes can bring its own set of… | Read More
Although much progress has been made in developing scientific knowledge and conducting clinical research in… | Read More
No longer the “what if” situation: today’s reality and eCOA back-up strategies.How to ensure they… | Read More
Funds will strengthen Kayentis’ digitalization approach in transforming how pharma, investigator sites and patients engage… | Read More
How to anticipate eCOA complexities and ensure a successful launch? Setting up a study with… | Read More
How to anticipate eCOA complexities in multi-year studies & develop best practice to support sites?… | Read More
“Through the quality of the solutions, services, and databases that we provide to sponsors and… | Read More
Carbon-neutral program takes aim at reducing CO2 emissions in clinical trials, particularly phase III, without… | Read More
Discover the 3 key advantages of using a single device for both on-site and home… | Read More
eCOA SETUP: HOW TO ENSURE A SUCCESSFUL LAUNCH BY NAVIGATING COMPLEXITIES Prepare Specifications: how to… | Read More
Focused on eCOA training, this white paper transcribes the discussion from one in a series… | Read More
A small tablet is the perfect choice between a smartphone and a “classic” tablet. A… | Read More
Embrace our spirit! With a 19% increase in new employees in 2019, the Kayentis team… | Read More
There is an extended use of Patient Reported Outcome (PRO) measures in clinical trials used… | Read More
With its strong experience in eCOA market, Kayentis introduces its new case study about oncology… | Read More
Discover below the 5 reasons to adopt eCOA solutions.Want to learn more about eCOA misconceptions?… | Read More
Although tablets and smartphones are widely used nowadays, not everybody is yet familiar with these… | Read More
Approximately one in every five pediatric clinical study fail1,2 . A 2016 study shows that over… | Read More
Before selecting a PRO for use in a large global trial, it is important to… | Read More
Acute Lymphoblastic or Lymphoid Leukemia (ALL) is a cancer of the lymphocytes that can result… | Read More
With the increasing importance of direct patient input into clinical trials, most protocols combine ePRO… | Read More
Emerging Biopharma & Biotech: discover below our 5 keys for successful eCOA trials!Want to learn… | Read More
When setting up Patient Reported Outcomes (PRO) for Clinical Trials, at some point you will… | Read More
Kayentis sets up incoming EBPs, major contributors in biomedical innovation, as well as its existing… | Read More
Electronic capture of patient data is increasingly replacing the use of paper-based diaries, and electronic… | Read More
Although clinical trials are meant to cover global populations, the pool of patients currently enrolled… | Read More
Although children make up 27% of the world’s population, at least 50% of all drug… | Read More
PROs in ophthalmology trials can either be self-administered by the patient or the responses can… | Read More
Although clinical research stakeholders strive to be patient-centered in their approach, dependence on clinical parameters… | Read More
Kayentis has a strong eCOA experience in autoimmune, inflammatory and dermatology diseases, thanks to 5… | Read More
Incorporating an economic evaluation within a trial provides valuable information for clinical decision making and… | Read More
There seems to be a lot of uncertainty here as people tend to think that… | Read More
Time is of the essence for any clinical study. Nobody wants to lose time when… | Read More
PROs have become a vital part of modern ophthalmology with an increasing focus on PROs… | Read More
A general misconception is that eCOA implementation will generate additional costs. Early investment is required… | Read More
The fear of losing data is more than legitimate. As clinical trial stakeholders you will have… | Read More
As “end users “of innovative technologies, site staff and patients need to embrace the digital… | Read More
Over recent years, as an industry, we seem to have created a paradox: we increase… | Read More
The decline in R&D efficiency is one of the biggest challenges the pharmaceutical industry is… | Read More
Digital solutions have without a doubt improved both the quality and the quantity of data… | Read More
Proximity will facilitate local and international sponsor access to Kayentis’ eCOA services for mid- to… | Read More
Digital innovation is increasingly penetrating the healthcare industry and technological advances create a new avenue… | Read More
Aware of its responsibility towards the environment, Kayentis decided to help financially two health-focused associations… | Read More
Kayentis announces that it has joined the C-Path’s ePRO Consortium, a nonprofit organization dedicated to… | Read More
eCOA study: the impact of a paper back-up system on data reliability In any eCOA… | Read More
25-year pharma industry veteran and clinical trials expert will strengthen Kayentis’ eCOA offering to sponsors… | Read More
This can only be the result of a balanced and robust Human Resources policy. … | Read More
The results are in! 2018 was marked by an increase of 35% in new employees… | Read More
Any enduring business relationship between a service provider and a client is built on a… | Read More
With a large patient pool and growing pharma market opportunities, study sites in China are… | Read More
Here are 6 reasons to knock at our door! At Kayentis, a global eCOA provider,… | Read More
Estelle Haenel has joined Kayentis as Medical Director. She will help leverage the company’s growing… | Read More
Kayentis is committed to responsible waste management After the promotion of environmentally friendly transport – 2018… | Read More
Interview with Björn Felber – Project Director, Kayentis US In June 2018, Kayentis was strengthening… | Read More
Why is there a need for a back-up solution? In some cases, the eCOA user… | Read More
Moving together towards a better tomorrow At Kayentis, we recognize that we all play a… | Read More
We are proud to announce our collaborative work with OMRON Healthcare on the development of… | Read More
Customer satisfaction survey 2018: The results are in! Rapid growth and diversification of clients brought… | Read More
Kayentis & RWS Life Sciences – Case Study Global Immunology and Dermatology Phase II Study… | Read More
The eCOA industry continues to evolve with yet more consolidation amongst traditional providers. Given the… | Read More
Kayentis, expert in eCOA, is stengthening its presence in the US and opening offices in… | Read More
Fort Lauderdale, FL – OmniComm Systems, Inc. (OTCQX: OMCM), a leading… | Read More
Well-being at Kayentis is rated 8/10! We are proud to publish the good results of… | Read More
A multi-platform eCOA solution to address the clinical trial needs of the future Over the… | Read More
Kayentis is a global eCOA vendor created in 2003, 100% dedicated to eCOA. Here is… | Read More
With a strong data management culture, Kayentis developed a process to ensure full data cleaning… | Read More
After a case study about autoimmune, inflammatory & skin diseases, Kayentis publishes its last case study specifically… | Read More
Mobile technology & wearable devices are becoming increasingly prominent in healthcare and clinical research, but… | Read More
Moving on from the “Selection & Evaluation of Technology Service Providers White Paper Part 1”,… | Read More
Joining Kayentis means also joining a company with its own values, a real vision and… | Read More
Digital technology today has become an important tool in facilitating access to and engagement with… | Read More
The European Union (EU) Data Protection Regulations (GPDR), effective from 27 April 2016, will apply to… | Read More
How the Agile mode, implemented in Kayentis’ R&D department, improves the quality of solutions as… | Read More
During a clinical trial, in particular for late phase trials, it becomes increasingly important to… | Read More
‘We are proud to announce that we have been accredited by the French Ministry of… | Read More
Advantages of eCOA: Clinical Outcomes Assessment (COA) data in clinical and epidemiological studies can be… | Read More
After case studies about autoimmune & skin diseases, psoriasis and oncology, Kayentis releases its cardiovascular case… | Read More
Over the last 25 years the collection of clinical research data has moved from paper-based… | Read More
Actigraphy has been used in clinical trials for almost 20 years. Recently their inclusion in… | Read More
In ePRO clinical trials, patients may use tablets to record their data. What if the… | Read More
Electronic tools allow the collection of data (electronic Clinical Outcomes Assessments [eCOA]) from patients, physicians,… | Read More
The past few years have seen a new breakthrough in electronic data capture: the electronic… | Read More
The FDA has provided guidance on methodology to be used for developing and using PRO… | Read More
High-frequency on-site monitoring with 100% source data verification does not necessarily improve data quality. New… | Read More
The constant increase in the volume of clinical data and the emergence of new technologies… | Read More
It is essential that clinicians review PRO data. When patients complete questionnaires using a tablet,… | Read More
You have chosen to use an eCOA solution in your clinical trial? Be aware of… | Read More
The FDA has provided guidance on methodology to be used for developing and using PRO… | Read More
Because it’s always more interesting to work with a strong eCOA partner, Kayentis enjoys a… | Read More
Diverse elements have combined in recent years to make Clinical Outcome Assessments (COAs), and particularly… | Read More
Because it’s better to use an eCOA solution that can operate with other devices, softwares… | Read More
Because Kayentis has the MOST INTEGRATED solution with SecureConsent® eICF, We have the most integrated… | Read More
The announcement in May 2016 of the partnership between Kayentis and SecureConsent was just the… | Read More
Because clinical trials can cost a lot, Kayentis allows you to reduce your costs We… | Read More
Kayentis proud to publish the results of its customer satisfaction survey Conducted among more than 60 Kayentis clients,… | Read More
Because risk-based monitoring is essential, We allow for a Risk-Based Monitoring strategy: Our projects gives… | Read More
Because patient compliance is key for the success of your study, Kayentis has DEDICATED tools to improve… | Read More
Because raw data are not enough, Kayentis delivers a FULLY CLEANED database, often ahead of schedule… | Read More
Because international studies must take account of customs issues, Kayentis has GLOBAL logistics expertise:… | Read More
Because connectivity is an important criteria to succeed in achieving eCOA, we have to take… | Read More
Because your data are precious, take care of data security and hosting! We have ALL… | Read More
Because every study is specific, it is never one size fits all. We have solutions for… | Read More
Because electronic data capture is complex, it’s better to work with expert vendors We are… | Read More
Innovation Capital and Extens finance 3.6 M€ round to accelerate the international growth of Kayentis. Kayentis,… | Read More
Choosing a provider in the clinical trials market is a costly and time-consuming process for… | Read More
Connectivity is key when using electronic Clinical Outcome Assessment (eCOA) tools in clinical studies. But… | Read More
Psoriasis is a chronic immune-mediated inflammatory disease of the skin with various presentations and clinical… | Read More
In recent years the use of electronic Clinical Outcome Assessment (eCOA) tools to improve clinical… | Read More
The patient’s role in clinical trials, as well as the general image of patient care,… | Read More
Several elements have to be respected in order to succeed in achieving a global eCOA… | Read More
Infography COA to eCOA: in many cases this move from COA to eCOA generates cost… | Read More
Benefits generated by a switch from COA to eCOA have already been clearly demonstrated by… | Read More
Authentication is a requirement that can’t be underestimated. It is key that user’s identity is… | Read More
KAYENTIS signs a partnership with eNFORME to combine SecureConsent® eICF solution with Kayentis eCOA’s platform…. | Read More
These phase III clinical studies, supported by Top10 pharma laboratories, will be using the tablet-based… | Read More
Four leading figures in Life Sciences have accepted director Guillaume Juge’s invitation to join the… | Read More
Kayentis finalized in February 2015 a round of funding with the arrival of Extens, a… | Read More